[Onset of type 1 diabetes after treatment with online-prescribed semaglutide].
semaglutide
Ugeskrift for laegerFeb 2026
GLP-1 Research Tracker
Every clinical trial and published study on semaglutide, tirzepatide, and next-generation GLP-1 medications — curated with plain-language summaries.
234 studies tracked·6 compounds covered·Updated Jul 2026
Tirzepatide in solid organ transplant recipients: Early real-world signals of efficacy and safety-A narrative review.
tirzepatide
Transplantation reviews (Orlando, Fla.)Feb 2026
Evaluating the Effects of Glucagon-Like Peptide 1 Receptor Agonists as a Secondary Prevention in Peripheral Arterial Disease: A Meta-Analysis.
Diabetes therapy : research, treatment and education of diabetes and related disordersFeb 2026
GLP-1 and the cardiovascular system.
semaglutidetirzepatideliraglutide
The Journal of clinical investigationFeb 2026
Preventive effect of liraglutide on postoperative delirium in elderly patients undergoing cardiac surgery: protocol for a single-centre, randomised, double-blind, placebo-controlled trial.
liraglutide
BMJ openFeb 2026
The Multifaceted Nature of GLP-1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases.
International journal of molecular sciencesFeb 2026
A Narrative Review on GLP-1 Receptor Agonists for Obesity in Older Women: Maximizing Weight Loss While Preserving Lean Mass.
semaglutidetirzepatide
NutrientsFeb 2026
Comparative Clinical and Metabolic Outcomes of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Type 1 Diabetes: A Retrospective Cohort Study from Saudi Arabia.
Current diabetes reviewsFeb 2026
Cardio-Obesity and Therapeutic Advances: Intersections Between Excess Adiposity, Cardiovascular Risk, and Pharmacologic Interventions.
tirzepatide
Current atherosclerosis reportsFeb 2026
Modern Management of CKM Syndrome: Use of GLP-1 Receptor Agonists in a Multidisciplinary Setting-Expert Group Recommendations from Kuwait.
semaglutide
Diabetes therapy : research, treatment and education of diabetes and related disordersFeb 2026
New-Onset Nonarteritic Anterior Ischemic Optic Neuropathy and Initiators of Semaglutide in US Veterans With Type 2 Diabetes.
semaglutide
JAMA ophthalmologyFeb 2026
Clinical Impact of Semaglutide Beyond Glycemic Control: A Critical Analysis of Oncogenic Potential and Mitigation of Cardiotoxicity.
semaglutide
Pharmaceuticals (Basel, Switzerland)Feb 2026
Renal and urothelial cancer risks with SGLT2 inhibitors vs GLP-1 receptor agonists in type 2 diabetes: a target trial emulation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationFeb 2026
GLP-1 receptor agonists and the risk of fragility fractures in older adults with type 2 diabetes.
The Journal of clinical endocrinology and metabolismFeb 2026
Sex-Based Differences in SGLT2i and GLP-1RA Use and Mortality in T2DM with Atherosclerotic Cardiovascular Disease.
BiomedicinesFeb 2026
Impact of Semaglutide on Limb Events: A Meta-Analysis of Randomized Controlled Trials.
semaglutide
European journal of preventive cardiologyFeb 2026
Medical treatment for diabetic acute kidney disease from 2012 to 2024: advances, prescription trends, and future directions.
Kidney research and clinical practiceFeb 2026
Effects of GLP-1 Receptor Agonists on Major Cardiovascular Events Among Patients with Atopic Dermatitis: A Population-Based Study.
Dermatitis : contact, atopic, occupational, drugFeb 2026
Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria.
Journal of personalized medicineFeb 2026
In vivo functional profiling and structural characterization of the human A316T variant.
Science advancesFeb 2026
Get Weekly Research Updates
New clinical trials, study results, and plain-language summaries delivered to your inbox.
Free weekly newsletter · No spam, unsubscribe anytime